Home › Lung Cancer › NCT06424327
A Registry for People With Lung Cancer
RecruitingObservational study
Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age ≥18 years * Patients suitable for segmentectomy, according to the treating surgeon * Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology Exclusion Criteria: * Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years * History of chemotherapy or radiation therapy for a previous lung cancer * Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery * Carcinoid tumors * History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix * Actively receiving treatment for other malignancies * Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis. * Multi-segmental resection from the same lobe is not a criterion for exclusion.
About the study
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
What is being tested
- Patient-Reported Outcomes Measurement Information System (other)
Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 600 · Started: May 15, 2024
Contact the study team
- David Jones, MD · Phone: 212-639-6428
- Bernard Park, MD · Phone: 646-888-3346
Official record on ClinicalTrials.gov — NCT06424327
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.